Iofetamine hydrochloride i-123 - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for iofetamine hydrochloride i-123 and what is the scope of freedom to operate?
Iofetamine hydrochloride i-123
is the generic ingredient in one branded drug marketed by IMP and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for iofetamine hydrochloride i-123
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Patent Applications: | 36 |
| DailyMed Link: | iofetamine hydrochloride i-123 at DailyMed |
Medical Subject Heading (MeSH) Categories for iofetamine hydrochloride i-123
US Patents and Regulatory Information for iofetamine hydrochloride i-123
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Imp | SPECTAMINE | iofetamine hydrochloride i-123 | INJECTABLE;INJECTION | 019432-001 | Dec 24, 1987 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for iofetamine hydrochloride i-123
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Imp | SPECTAMINE | iofetamine hydrochloride i-123 | INJECTABLE;INJECTION | 019432-001 | Dec 24, 1987 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
